Generation of a TPM1 homozygous knockout embryonic stem cell line by CRISPR/Cas9 editing

被引：5
|
作者：
Ma, Shuhong [1 ,2 ]
Xu, Qi [3 ]
Bai, Rui [1 ,2 ]
Dong, Tao [1 ,2 ]
Peng, Zhiping [4 ]
Liu, Xujie [4 ]
机构：
[1] Capital Med Univ, Anzhen Hosp, Beijing 100029, Peoples R China
[2] Beijing Inst Heart Lung & Blood Vessel Dis, Beijing 100029, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Fuwai Hosp, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Beijing 100037, Peoples R China
[4] Chongqing Med Univ, Basic Med Sch, Dept Radiol, Chongqing 400016, Peoples R China
来源：
STEM CELL RESEARCH | 2021年 / 55卷
基金：
中国国家自然科学基金; 北京市自然科学基金;
关键词：
D O I：
10.1016/j.scr.2021.102470
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
Alpha-Tropomyosin (TPM1) plays a crucial role in actin regulation and stability and contributes fundamental functions to heart development: without TPM1 expressing, mice embryos will die early in embryogenesis. To further identify the role of TPM1 in human cardiac development, here we generated a homozygous TPM1 knockout (TPM1(-/-)) human embryonic stem cell (hESC) line using CRISPR/Cas9-based genome editing system. The generated TPM1(-/-) hESC line maintained normal karyotype, highly expressed pluripotency markers and was able to differentiate into all three germ layers in vivo. This cell line provides a powerful tool to investigate the role of TPM1 in heart development in future.
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Generation of two RNF2 homozygous knockout human embryonic stem cell lines by CRISPR/Cas9 system
    Shan, Yongli
    Ma, Lishi
    Zhang, Cong
    Zhang, Yanqi
    Zhang, Jingyuan
    Xiao, Lu
    Wei, Yanxing
    Yu, Yanhong
    STEM CELL RESEARCH, 2020, 47
  • [32] Generation of an Abcc8 homozygous mutation human embryonic stem cell line using CRISPR/Cas9
    Guo, Dongsheng
    Liu, Haikun
    Gao, Ge
    Ruzi, Aynisahan
    Wang, Kepin
    Wu, Han
    Lai, Keyu
    Liu, Yanli
    Yang, Fan
    Lai, Liangxue
    Li, Yin-xiong
    STEM CELL RESEARCH, 2016, 17 (03) : 640 - 642
  • [33] A homozygous Keap1-knockout human embryonic stem cell line generated using CRISPR/Cas9 mediates gene targeting
    Kim, So-Jung
    Habib, Omer
    Kim, Jin-Soo
    Han, Hyo-Won
    Koo, Soo Kyung
    Kim, Jung-Hyun
    STEM CELL RESEARCH, 2017, 19 : 52 - 54
  • [34] Generation of a RGS18 gene knockout cell line from a human embryonic stem cell line by CRISPR/Cas9
    Feng, Yashu
    Li, Xudong
    Zhang, Ling
    Sun, Yanling
    He, Yi
    Wen, Ruijuan
    Hu, Yaofang
    Wang, Xiaozhen
    Liu, Jiajun
    Long, Bing
    STEM CELL RESEARCH, 2020, 49
  • [35] Generation of a homozygous LRP2 knockout human embryonic stem cell line (FDCHDPe010-A-56) by CRISPR/Cas9 system
    You, Jie
    Cheng, Yun
    Yang, Xian-Jie
    Chen, Ling
    STEM CELL RESEARCH, 2021, 53
  • [36] Generation of a KCNJ11 homozygous knockout human embryonic stem cell line WAe001-A-12 using CRISPR/Cas9
    Yuan, Fang
    Guo, Dongsheng
    Gaob, Ge
    Liu, Yanli
    Xu, Yingying
    Wu, Yuhang
    Yang, Fan
    Ke, Xinrong
    Lai, Keyu
    Hong, Liangqing
    Li, Yin-xiong
    STEM CELL RESEARCH, 2017, 24 : 89 - 93
  • [37] Generation of a TBX20-knockout human embryonic stem line by CRISPR/Cas9 system
    Wu, Xiaodan
    Wang, Xiantao
    STEM CELL RESEARCH, 2023, 69
  • [38] Generation of a KDM5D knockout human embryonic stem cell line with CRISPR/Cas9 technology
    Li, Ouhui
    Zhen, Yuting
    Sun, Chao
    Ma, Yanlin
    Li, Qi
    Wen, Luan
    STEM CELL RESEARCH, 2025, 83
  • [39] Generation of GPAM knockout human embryonic stem cell line SYSUe-008-A using CRISPR/Cas9
    Sun, Chuanbo
    Li, Bing
    Yang, Miaomiao
    Guo, Ruirui
    Yuan, Simin
    Wang, Jichang
    Hu, Hao
    STEM CELL RESEARCH, 2021, 53
  • [40] Generation of CD16A gene knockout human embryonic stem cell line using CRISPR/Cas9
    Wu, Shunjie
    Deng, Haimei
    Lu, Bo
    Yuan, Lihua
    Wang, Xiaobo
    STEM CELL RESEARCH, 2022, 64
12345